Found: 68
Select item for more details and to access through your institution.
Early and delayed thallium 201 imaging. Diagnosis of patients with cold thyroid nodules.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Electrophysiological, Rate Dependent, and Autonomic Effects of the Class III Antiarrhythmic Almokalant After Myocardial Infarction in the Pig.
- Published in:
- Pacing & Clinical Electrophysiology, 1996, v. 19, n. 5, p. 802, doi. 10.1111/j.1540-8159.1996.tb03362.x
- By:
- Publication type:
- Article
Late Potentials in a Porcine Model of Anterior Wall Myocardial Infarction and Their Relation to Inducible Ventricular Tachycardia.
- Published in:
- Pacing & Clinical Electrophysiology, 1992, v. 15, n. 11, p. 1760, doi. 10.1111/j.1540-8159.1992.tb02964.x
- By:
- Publication type:
- Article
Effects of Image Characteristics on Performance of Tumor Delineation Methods: A Test--Retest Assessment.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1550, doi. 10.2967/jnumed.111.088914
- By:
- Publication type:
- Article
Monitoring Response to Antiangiogenic Therapy in Non--Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 1, p. 48, doi. 10.2967/jnumed.110.078261
- By:
- Publication type:
- Article
Repeatability of Metabolically Active Volume Measurements with <sup>18</sup>F-FDG and <sup>18</sup>F-FLT PET in Non--Small Cell Lung Cancer.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 12, p. 1870, doi. 10.2967/jnumed.110.077255
- By:
- Publication type:
- Article
Reproducibility of Tumor Perfusion Measurements Using <sup>15</sup>O-Labeled Water and PET.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1763, doi. 10.2967/jnumed.108.053454
- By:
- Publication type:
- Article
Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 10, p. 2507, doi. 10.1007/s11095-022-03355-2
- By:
- Publication type:
- Article
Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: Prostaglandins and bradykinin.
- Published in:
- European Heart Journal, 1990, v. 11, n. suppl_B, p. 84, doi. 10.1093/eurheartj/11.suppl_b.84
- By:
- Publication type:
- Article
Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 5, p. 343, doi. 10.1007/s00228-006-0102-6
- By:
- Publication type:
- Article
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.
- Published in:
- Nature Protocols, 2024, v. 19, n. 3, p. 700, doi. 10.1038/s41596-023-00933-5
- By:
- Publication type:
- Article
Critical Factors Affecting Quality of Life of Adult Patients With Anorectal Malformations or Hirschsprung's Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2004, v. 99, n. 5, p. 907, doi. 10.1111/j.1572-0241.2004.04149.x
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Hot topics Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236091
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Hot topics Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Hot topics: Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Hot topics Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Imaging responses to immunotherapy with novel PET tracers.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.236158
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with <sup>18</sup>F-Fluoroazomycin Arabinoside and <sup>15</sup>O-H<sub>2</sub>O PET.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 4, p. 530, doi. 10.2967/jnumed.115.166579
- By:
- Publication type:
- Article
Repeatability of <sup>18</sup>F-FDG Uptake Measurements in Tumors: A Metaanalysis.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 5, p. 701, doi. 10.2967/jnumed.111.095299
- By:
- Publication type:
- Article
Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1347, doi. 10.1002/onco.13580
- By:
- Publication type:
- Article
Use of H<sub>2</sub><sup>15</sup>O-PET and DCE-MRI to Measure Tumor Blood Flow.
- Published in:
- Oncologist, 2008, v. 13, n. 6, p. 631, doi. 10.1634/theoncologist.2007-0235
- By:
- Publication type:
- Article
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 601, doi. 10.1016/j.cllc.2021.06.006
- By:
- Publication type:
- Article
Relationship between Biodistribution and Tracer Kinetics of 11 C-Erlotinib, 18 F-Afatinib and 11 C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 883, doi. 10.3390/diagnostics12040883
- By:
- Publication type:
- Article
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
- By:
- Publication type:
- Article
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 683, doi. 10.1002/cncr.35090
- By:
- Publication type:
- Article
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice.
- Published in:
- Journal of Pathology, 2022, v. 258, n. 2, p. 179, doi. 10.1002/path.5988
- By:
- Publication type:
- Article